Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Jul;65(1):90–99.

Variability in B cell maturation and differentiation in X-linked agammaglobulinemia.

F E Leickley, R Buckley
PMCID: PMC1542276  PMID: 3491702

Abstract

Among seven males with X-linked agammaglobulinemia in an extended pedigree, serum immunoglobulins and antibodies were extremely low in all but one who had a normal IgA (78 mg/dl) and tetanus antibodies (1:19,683). Following bacteriophage phi X 174 immunizations, the oldest failed to clear phage and had no primary or secondary antibody responses. The youngest had normal phage clearance, low primary and secondary antibody responses, and no amplification or switching to IgG. The other four affected had normal or slightly delayed phage clearance, low primary and secondary responses, but some amplification and switching from IgM to IgG which increased with age. Normal percentages of surface immunoglobulin positive cells were present in the two youngest patients, but all seven affected had very low percentages of cells reacting with monoclonal antibodies to B cell surface antigens. Immunoglobulin production by cultured blood B cells was very low and not increased by pokeweed mitogen. However, a majority of Epstein-Barr virus (EBV)-transformed lymphoblastoid cells derived from the blood of four of the patients bore IgD and IgM and reacted with all of the monoclonal antibodies to B cell antigens. Culture supernatants from those lines contained significant quantities of IgM and lesser amounts of IgG and IgA. The studies presented here provide further support for the hypothesis that the primary abnormality in X-linked agammaglobulinemia affects B cells at more than one stage of development rather than just at the level of the pre-B cell.

Full text

PDF
90

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson C. S., Kersey J. H., LeBien T. W. A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. J Immunol. 1981 Jan;126(1):83–88. [PubMed] [Google Scholar]
  2. Adam A., Levin S., Arnon A., Sadan N., Klajman A. X-linked hypogammaglobulinemia. Additional observations in a previously reported family. Isr J Med Sci. 1971 Nov;7(11):1280–1285. [PubMed] [Google Scholar]
  3. Buckley R. H., Dees S. C., O'Fallon W. M. Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy. Pediatrics. 1968 Mar;41(3):600–611. [PubMed] [Google Scholar]
  4. Buckley R. H., Dees S. C. Serum immunoglobulins. 3. Abnormalities associated with chronic urticaria in children. J Allergy. 1967 Nov;40(5):294–303. doi: 10.1016/0021-8707(67)90077-9. [DOI] [PubMed] [Google Scholar]
  5. Buckley R. H., Fiscus S. A. Serum IgD and IgE concentrations in immunodeficiency diseases. J Clin Invest. 1975 Jan;55(1):157–165. doi: 10.1172/JCI107906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Buckley R. H., MacQueen J. M., Ward F. E. HLA antigens in primary immunodeficiency diseases. Clin Immunol Immunopathol. 1977 May;7(3):305–310. doi: 10.1016/0090-1229(77)90061-7. [DOI] [PubMed] [Google Scholar]
  7. Conley M. E. B cells in patients with X-linked agammaglobulinemia. J Immunol. 1985 May;134(5):3070–3074. [PubMed] [Google Scholar]
  8. Cooper M. D. Pre-B cells; normal and abnormal development. J Clin Immunol. 1981 Apr;1(2):81–89. doi: 10.1007/BF00915383. [DOI] [PubMed] [Google Scholar]
  9. Fu S. M., Hurley J. N., McCune J. M., Kunkel H. G., Good R. A. Pre-B cells and other possible precursor lymphoid cell lines derived from patients with X-linked agammaglobulinemia. J Exp Med. 1980 Dec 1;152(6):1519–1526. doi: 10.1084/jem.152.6.1519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Geha R. S., Rosen F. S., Merler E. Identification and characterization of subpopulations of lymphocytes in human peripheral blood after fractionation on discontinuous gradients of albumin. The cellular defect in X-linked agammaglobulinemia. J Clin Invest. 1973 Jul;52(7):1726–1734. doi: 10.1172/JCI107354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goldblum R. M., Lord R. A., Cooper M. D., Gathings W. E., Goldman A. S. X-linked B lymphocyte deficiency. I. Panhypo-gamma-globulinemia and dys-gamma-globulinemia in siblings. J Pediatr. 1974 Aug;85(2):188–191. doi: 10.1016/s0022-3476(74)80390-2. [DOI] [PubMed] [Google Scholar]
  12. Haynes B. F. Human T lymphocyte antigens as defined by monoclonal antibodies. Immunol Rev. 1981;57:127–161. doi: 10.1111/j.1600-065x.1981.tb00445.x. [DOI] [PubMed] [Google Scholar]
  13. Krantman H. J., Saxon A., Stevens R. H., Stiehm E. R. Phenotypic heterogeneity in X-linked infantile agammaglobulinemia with in vitro monocyte suppression of immunoglobulin synthesis. Clin Immunol Immunopathol. 1981 Aug;20(2):170–178. doi: 10.1016/0090-1229(81)90175-6. [DOI] [PubMed] [Google Scholar]
  14. Landreth K. S., Engelhard D., Anasetti C., Kapoor N., Kincade P. W., Good R. A. Pre-B cells in agammaglobulinemia: evidence for disease heterogeneity among affected boys. J Clin Immunol. 1985 Mar;5(2):84–89. doi: 10.1007/BF00915005. [DOI] [PubMed] [Google Scholar]
  15. Levitt D., Ochs H., Wedgwood R. J. Epstein-Barr virus-induced lymphoblastoid cell lines derived from the peripheral blood of patients with X-linked agammaglobulinemia can secrete IgM. J Clin Immunol. 1984 Mar;4(2):143–150. doi: 10.1007/BF00915048. [DOI] [PubMed] [Google Scholar]
  16. Nadler L. M., Stashenko P., Hardy R., van Agthoven A., Terhorst C., Schlossman S. F. Characterization of a human B cell-specific antigen (B2) distinct from B1. J Immunol. 1981 May;126(5):1941–1947. [PubMed] [Google Scholar]
  17. Ochs H. D., Davis S. D., Wedgwood R. J. Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases. J Clin Invest. 1971 Dec;50(12):2559–2568. doi: 10.1172/JCI106756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Preud'Homme J. L., Griscelli C., Seligmann M. Immunoglobulins on the surface of lymphocytes in fifty patients with primary immunodeficiency diseases. Clin Immunol Immunopathol. 1973 Jan;1(2):241–256. doi: 10.1016/0090-1229(73)90025-1. [DOI] [PubMed] [Google Scholar]
  19. Reinherz E. L., Schlossman S. F. Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med. 1980 Aug 14;303(7):370–373. doi: 10.1056/NEJM198008143030704. [DOI] [PubMed] [Google Scholar]
  20. Rosen F. S., Cooper M. D., Wedgwood R. J. The primary immunodeficiencies (1). N Engl J Med. 1984 Jul 26;311(4):235–242. doi: 10.1056/NEJM198407263110406. [DOI] [PubMed] [Google Scholar]
  21. Rosenthal P., Rimm I. J., Umiel T., Griffin J. D., Osathanondh R., Schlossman S. F., Nadler L. M. Ontogeny of human hematopoietic cells: analysis utilizing monoclonal antibodies. J Immunol. 1983 Jul;131(1):232–237. [PubMed] [Google Scholar]
  22. Schiff R. I., Buckley R. H., Gilbertsen R. B., Metzgar R. S. Membrane receptors and in vitro responsiveness of lymphocytes in human immunodeficiency. J Immunol. 1974 Jan;112(1):376–386. [PubMed] [Google Scholar]
  23. Schwaber J., Molgaard H., Orkin S. H., Gould H. J., Rosen F. S. Early pre-B cells from normal and X-linked agammaglobulinaemia produce C mu without an attached VH region. 1983 Jul 28-Aug 3Nature. 304(5924):355–358. doi: 10.1038/304355a0. [DOI] [PubMed] [Google Scholar]
  24. Siegal F. P., Pernis B., Kunkel H. G. Lymphocytes in human immunodeficiency states: a study of membrane-associated immunoglobulins. Eur J Immunol. 1971 Dec;1(6):482–486. doi: 10.1002/eji.1830010615. [DOI] [PubMed] [Google Scholar]
  25. Stashenko P., Nadler L. M., Hardy R., Schlossman S. F. Characterization of a human B lymphocyte-specific antigen. J Immunol. 1980 Oct;125(4):1678–1685. [PubMed] [Google Scholar]
  26. WALLENBORN P. A., Jr Agammaglobulinemia. Report of two cases and review of literature. Laryngoscope. 1960 Jan;70:1–36. doi: 10.1288/00005537-196001000-00001. [DOI] [PubMed] [Google Scholar]
  27. Waldmann T. A., Durm M., Broder S., Blackman M., Blaese R. M., Strober W. Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet. 1974 Sep 14;2(7881):609–613. doi: 10.1016/s0140-6736(74)91940-0. [DOI] [PubMed] [Google Scholar]
  28. Wedgwood R. J., Ochs H. D., Davis S. D. The recognition and classification of immunodeficiency diseases with bacteriophage phiChi 174. Birth Defects Orig Artic Ser. 1975;11(1):331–338. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES